1. Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: A feasibility study
- Author
-
Reesink-Peters, N., Wisman, G. B. A., Jéronimo, C., Tokumaru, C. Y., Cohen, Y., Dong, S. M., Klip, H. G., Buikema, H. J., Albert Suurmeijer, Hollema, H., Boezen, H. M., Sidransky, D., Zee, A. G. J., Targeted Gynaecologic Oncology (TARGON), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Life Course Epidemiology (LCE), and Groningen Research Institute for Asthma and COPD (GRIAC)
- Subjects
SMEAR ,AGE ,CARCINOMA ,TISSUE ,MULTIPLE GENES ,TUMOR-SUPPRESSOR ,NEOPLASIA ,DNA METHYLATION ,DISEASE ,SERUM - Abstract
Current morphology-based cervical cancer screening is associated with significant false-positive and false-negative results. Tumor suppressor gene hypermethylation is frequently present in cervical cancer. It is unknown whether a cervical scraping reflects the methylation status of the underlying epithelium, and it is therefore unclear whether quantitative hypermethylation specific PCR (QMSP) on cervical scrapings could be used as a future screening method augmenting the current approach. Cervical scrapings and paired fresh frozen cervical tissue samples were obtained from 53 cervical cancer patients and 45 controls. All scrapings were morphologically scored and analyzed with QMSP for the genes APC, DAPK, MGMT, and GSTP1. To adjust for DNA input, hypermethylation ratios were calculated against DNA levels of a reference gene. Hypermethylation ratios of paired fresh frozen tissue samples and scrapings of cervical cancer patients and controls were strongly related (Spearman correlation coefficient, 0.80 for APC, 0.98 for DAPK, and 0.83 for MGMT; P
- Published
- 2004